Boule Diagnostics Ab Stock Current Ratio
| BOUL Stock | SEK 8.82 0.24 2.65% |
Boule Diagnostics AB fundamentals help investors to digest information that contributes to Boule Diagnostics' financial success or failures. It also enables traders to predict the movement of Boule Stock. The fundamental analysis module provides a way to measure Boule Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boule Diagnostics stock.
Boule |
Boule Diagnostics AB Company Current Ratio Analysis
Boule Diagnostics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Boule Diagnostics Current Ratio | 1.30 X |
Most of Boule Diagnostics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boule Diagnostics AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Boule Diagnostics AB has a Current Ratio of 1.3 times. This is 55.33% lower than that of the Health Care Equipment & Supplies sector and 70.85% lower than that of the Health Care industry. The current ratio for all Sweden stocks is 39.81% higher than that of the company.
Boule Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boule Diagnostics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boule Diagnostics could also be used in its relative valuation, which is a method of valuing Boule Diagnostics by comparing valuation metrics of similar companies.Boule Diagnostics is currently under evaluation in current ratio category among its peers.
Boule Fundamentals
| Return On Equity | 0.0335 | |||
| Return On Asset | 0.0271 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 562.26 M | |||
| Shares Outstanding | 38.83 M | |||
| Shares Owned By Insiders | 12.64 % | |||
| Shares Owned By Institutions | 27.69 % | |||
| Price To Earning | 24.26 X | |||
| Price To Book | 1.06 X | |||
| Price To Sales | 0.68 X | |||
| Revenue | 463.34 M | |||
| Gross Profit | 227.9 M | |||
| EBITDA | 55.69 M | |||
| Net Income | 23.27 M | |||
| Cash And Equivalents | 38.18 M | |||
| Cash Per Share | 0.87 X | |||
| Total Debt | 50.6 M | |||
| Debt To Equity | 46.00 % | |||
| Current Ratio | 1.30 X | |||
| Book Value Per Share | 11.91 X | |||
| Cash Flow From Operations | 43.28 M | |||
| Earnings Per Share | 0.96 X | |||
| Target Price | 87.0 | |||
| Number Of Employees | 200 | |||
| Beta | 0.58 | |||
| Market Capitalization | 532.01 M | |||
| Total Asset | 572.03 M | |||
| Retained Earnings | (6 M) | |||
| Working Capital | 65 M | |||
| Current Asset | 135 M | |||
| Current Liabilities | 70 M | |||
| Z Score | 6.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 0.73 % | |||
| Net Asset | 572.03 M |
About Boule Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boule Diagnostics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boule Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boule Diagnostics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.